Physician

Amber Lynn Sobuto, D.O.

According to 2025 Medicare claims, Amber Sobuto, D.O. (NPI: 1124361977) practices hematology/oncology in the Scranton--Wilkes-Barre, PA market, with the plurality of this provider's patient population coming from Lackawanna, PA. This provider's primary affiliated billing organization is HEMATOLOGY AND ONCOLOGY ASSOCIATES OF NORTHEASTERN PA, PC (NPI: 1164538724; TIN: 232137083) and primary practice location at 18512-3169. Sobuto is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Sobuto's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 719 traditional Medicare patients, billed 173,785 HCPCS/CPT codes, and received $4,052,018 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,222 prescription claims across 217 beneficiaries totaling $4,579,162 in drug costs, led by Ibrance (Palbociclib). DME data shows 77 claims. Open Payments data shows 22 records totaling $646. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $66,726 to $4,052,018. Similarly, Part D prescription costs have moved sharply higher in recent years, from $26,619 to $4,579,162. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	85	9,854	$66,726
2020	321	26,090	$419,015
2021	818	84,386	$1,386,004
2022	728	164,264	$1,969,054
2023	724	144,398	$3,186,993
2024	719	173,785	$4,052,018

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	60	470	$26,619
2016	76	489	$73,919
2017	28	166	$87,811
2018	26	161	$134,977
2019	63	224	$592,735
2020	98	350	$1,032,563
2021	158	629	$1,049,101
2022	153	654	$2,352,894
2023	180	1,010	$4,054,303
2024	217	1,222	$4,579,162

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	77	$2,013

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	353	589	$87
82728	Ferritin (blood protein) level	255	447	$13
80053	Blood test, comprehensive group of blood chemicals	569	1,711	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	578	1,802	$8
83540	Iron level	251	442	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	63	1,764	$1,006,585
Imbruvica	Ibrutinib	34	952	$589,795
Lenalidomide	Lenalidomide	44	1,197	$546,983
Brukinsa	Zanubrutinib	31	930	$459,417
Vonjo	Pacritinib Citrate	13	390	$341,309

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	19	$769
J8999	Prescription drug, oral, chemotherapeutic, nos	N	N/R	15	$535
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	23	$433
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	20	$276

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$646	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amber Lynn Sobuto, D.O.?

Tedicare shows public-source Medicare data for Amber Lynn Sobuto, D.O. (NPI 1124361977), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amber Lynn Sobuto, D.O. have ACO affiliation data?

Amber Lynn Sobuto, D.O. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Amber Lynn Sobuto, D.O.?

Amber Lynn Sobuto, D.O. is linked to HEMATOLOGY AND ONCOLOGY ASSOCIATES OF NORTHEASTERN PA, PC (billing NPI 1164538724) in the available physician profile data.

Does Amber Lynn Sobuto, D.O. have Open Payments data?

Amber Lynn Sobuto, D.O. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.